ALEXANDER v. CVS PHARMACY, INC.

CourtDistrict Court, S.D. Indiana
DecidedJanuary 8, 2024
Docket4:23-cv-00085
StatusUnknown

This text of ALEXANDER v. CVS PHARMACY, INC. (ALEXANDER v. CVS PHARMACY, INC.) is published on Counsel Stack Legal Research, covering District Court, S.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ALEXANDER v. CVS PHARMACY, INC., (S.D. Ind. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA NEW ALBANY DIVISION

ANTHONY ALEXANDER, et al., ) ) Plaintiffs, ) ) v. ) No. 4:23-cv-00085-SEB-KMB ) CVS PHARMACY, INC., A RHODE ) ISLAND CORPORATION, ) ) Defendant. )

ORDER GRANTING DEFENDANT'S MOTION TO DISMISS

Now before the Court is the Motion to Dismiss [Dkt. 16] filed by Defendant CVS Pharmacy, Inc. ("CVS") challenging the legal sufficiency of the Complaint brought by Plaintiffs Anthony Alexander, M.D. and the Pain Medicine and Rehabilitation Center. For the reasons detailed below, the Motion to Dismiss must be GRANTED.1 Factual Background Anthony Alexander, M.D., is a board-certified anesthesiologist licensed in Indiana and Illinois. In addition to his medical licenses, he also maintains valid DEA and Indiana controlled substance registrations. Dr. Alexander owns and operates the Pain Medicine & Rehabilitation Center (the "Center"), an Indiana professional corporation with offices in Seymour and Jeffersonville, Indiana, which offices were opened in 2001 and 2009, respectively. A majority of the patients Dr. Alexander treats suffer from chronic

1 On December 12, 2023, Defendant filed a Motion for Leave to File Notice of Supplemental Authority [Dkt. 27]. That motion is hereby GRANTED. intractable pain, cancer, or terminal illness. Based on this patient population, prescribing controlled substances to manage pain is a pivotal component of Dr. Alexander's practice

and treatment of his patients. In addition to running his practice, Dr. Alexander also maintains an active role in developing and supporting legislation aimed at aiding pain patients, including the Indiana Pain Management Prescribing Final Rule, adopted by the Indiana Medical Licensing Board in September 2014. In December 2014, the Indiana Attorney General investigated Dr. Alexander and the Center for alleged improper medical billing and controlled substance prescribing

practices. As part of the investigation, a search warrant was executed at Dr. Alexander's offices, staff members were interviewed, and a review of medical and business records was conducted. Plaintiffs allege that this investigation was prompted by the Indiana Board of Pharmacy after it received "data" from CVS that CVS claimed called into question Dr. Alexander's prescribing patterns. Plaintiffs allege that the "data" was

generated by risk management software CVS utilizes to monitor the prescribing patterns of physicians based on unknown parameters, which do not include patient-by-patient evaluation of medical necessity by a licensed pharmacist, as is required by federal and state regulation. According to Plaintiffs, CVS used its risk management software to support its decision to ban its pharmacies in all 50 states from filling Dr. Alexander's

prescriptions beginning in February 2015 and continuing through the present. While the Indiana Attorney General's investigation remained open, Dr. Alexander on several occasions attempted to discuss the issue with CVS, to no avail. On May 4, 2016, Dr. Alexander was informed by CVS that because it had purchased Target Pharmacies, those pharmacies would no longer be filling his prescriptions. On May 9, 2016, Dr. Alexander again attempted to resolve the issue. In response, CVS provided Dr.

Alexander a survey/questionnaire regarding his prescribing practices to complete and return. Although Dr. Alexander completed the form and returned it to CVS, the ban was not lifted. On December 30, 2019, the Indiana Attorney General's office issued a letter to Dr. Alexander advising him that the investigation was being closed. No charges, arrests, civil infractions, or any other findings of wrongdoing resulted from the investigation. In

January 2020, Dr. Alexander provided a copy of the Attorney General's letter to CVS but received no response from the company. In August 2022, Dr. Alexander again reached out to CVS regarding honoring his prescriptions. In September 2022, he received a letter and survey in the mail from CVS, but when he called CVS and asked to speak with someone regarding the information he received, no manager or other CVS representative

ever returned his call. To date, despite having provided the requested information regarding Dr. Alexander's prescribing practices and being advised that the investigation into his billing and prescribing practices was closed without any action by the State of Indiana, CVS continues instructing its pharmacies not to fill Dr. Alexander's prescriptions.

In Dr. Alexander's 29 years of treating patients, no other pharmacy has refused to fill controlled substance prescriptions written by him. However, due to CVS's large market share, its ban severely limits where Dr. Alexander's patients can fill their prescriptions, and as a result, he has either lost or had to turn away thousands of patients because he is unable to properly manage their medical conditions. Plaintiffs allege that, in 2021 and 2022, for example, as a result of CVS's ban, they have lost 275 to 300

patients and 25 to 30 referral partners in each of those years. Since the ban was imposed in 2015, Plaintiffs have also lost millions of dollars in revenue. While the Center's operations costs vary from year to year, from 2015 to the present, the annual cost of operations exceeds $1.1 million. The Center had a net loss of over $300,000 in 2022 and expects an even more significant loss in 2023. Plaintiffs allege that if CVS's ban on filling Dr. Alexander's prescriptions continues, he will be forced to close his practice.

Based on these facts, Plaintiffs allege a state law tortious interference with a business relationship claim as well as a claim for injunctive relief enjoining CVS from continuing to ban its pharmacies from filling Dr. Alexander's prescriptions. Now before the Court is CVS's motion to dismiss, which is fully briefed and ripe for ruling. Legal Analysis

I. Motion to Dismiss Standard In resolving a motion to dismiss filed pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, the Court accepts as true all "well-pleaded factual allegations" in the Complaint and draws all ensuing inferences in favor of the non-movant. Lake v. Neal, 585 F.3d 1059, 1060 (7th Cir. 2009). Regarding the legal sufficiency of the claims,

the Court asks "whether they plausibly give rise to an entitlement to relief." Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009). The Court focuses on the well-pleaded facts, as opposed to conclusory statements or "threadbare recitals of the elements of a cause of action," in an effort to determine whether the factual averments "permit the court to infer more than the mere possibility of misconduct." Id. With these principles in mind, we examine below each of Dr. Leer's claims for relief to determine whether under the

applicable Indiana legal principles/statutes it states a claim upon which relief can be granted. II. Discussion A. Count I – Tortious Interference With a Business Relationship In Count I, Plaintiffs allege that the business relationships Dr. Alexander had established with his patients and his referral partners were intentionally interfered with by

CVS when it refused to honor his prescriptions for controlled substances, thereby causing Plaintiffs economic injury and monetary damages. CVS argues that this claim must be dismissed because it is barred by the applicable statute of limitations, and, even if not barred, fails to state a plausible claim for relief. We address these arguments in turn below.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Brazauskas v. Fort Wayne-South Bend Diocese, Inc.
796 N.E.2d 286 (Indiana Supreme Court, 2003)
Lake v. Neal
585 F.3d 1059 (Seventh Circuit, 2009)
Brooks v. Ross
578 F.3d 574 (Seventh Circuit, 2009)
Government Payment Service, Inc. v. Ace Bail Bonds
854 N.E.2d 1205 (Indiana Court of Appeals, 2006)
Levee v. Beeching
729 N.E.2d 215 (Indiana Court of Appeals, 2000)
C & E CORP. v. Ramco Industries, Inc.
717 N.E.2d 642 (Indiana Court of Appeals, 1999)
Bilimoria Computer Systems, LLC v. America Online, Inc.
829 N.E.2d 150 (Indiana Court of Appeals, 2005)
Brian Knutson v. Village of Lakemoor
932 F.3d 572 (Seventh Circuit, 2019)
Snyder v. Town of Yorktown
20 N.E.3d 545 (Indiana Court of Appeals, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
ALEXANDER v. CVS PHARMACY, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/alexander-v-cvs-pharmacy-inc-insd-2024.